https://www.selleckchem.com/products/ABT-263.html
Melflufen, a substrate of aminopeptidase B, efficiently eliminates bortezomib-resistant myeloma cells in vitro and in vivo, and completely suppresses clonogenic myeloma growth in vitro at subphysiological concentrations. Thus, melflufen represents a novel treatment option that is able to eradicate drug-resistant myeloma clones characterized by elevated aminopeptidase B expression.Background To reach global goals related to women and girls' access to modern family planning (FP) and gender equality, evidence shows that it is critical to u
Like
Comment
Share
